Local and systemic control in Ewing's sarcoma of the femur treated with chemotherapy, and locally by radiotherapy and/or surgery

G. Bacci, S. Ferrari, A. Longhi, M. Versari, C. Forni, D. Donati, M. Manfrini, P. Trentani, E. Barbieri

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

The role of radiotherapy and/or surgery in the local treatment of Ewing's sarcoma has still to be determined. The outcome of Ewing's sarcoma may differ according to its location and a selection bias towards surgery limits the ability to compare methods of local treatment. We have carried out a retrospective review of 91 consecutive patients treated for non-metastatic Ewing's sarcoma of the femur. They received chemotherapy according to four different protocols. The primary lesion was treated by surgery alone (54 patients), surgery and radiotherapy (13) and radiotherapy alone (23). One was treated by chemotherapy alone. At a median follow-up of ten years, 48 patients (53%) remain free from disease, 39 (43%) have relapsed, two (2%) have died from chemotherapeutic toxicity and two (2%) have developed a radio-induced second tumour. The probability of survival without local recurrence was significantly (p = 0.01) higher in patients who were treated by surgery with or without radiotherapy (88%) than for patients who received radiotherapy alone (59%). The five- and ten-year overall survival rates were 64% and 57%, respectively. Patients who were treated by surgery, with or without radiotherapy, had a five- and ten-year overall survival of 64%. Patients who received only radiotherapy had a five- and ten-year survival of 57% and 44%, respectively. Our results indicate that in patients with Ewing's sarcoma of the femur, better local control is achieved by surgical treatment (with or without radiotherapy) compared with the use of radiotherapy alone. Further studies are needed to verify the impact of this strategy on overall survival.

Original languageEnglish
Pages (from-to)107-114
Number of pages8
JournalJournal of Bone and Joint Surgery - Series B
Volume85
Issue number1
DOIs
Publication statusPublished - Jan 2003

Fingerprint

Ewing's Sarcoma
Femur
Radiotherapy
Drug Therapy
Survival
Selection Bias
Radio
Therapeutics
Survival Rate
Recurrence

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Surgery

Cite this

Local and systemic control in Ewing's sarcoma of the femur treated with chemotherapy, and locally by radiotherapy and/or surgery. / Bacci, G.; Ferrari, S.; Longhi, A.; Versari, M.; Forni, C.; Donati, D.; Manfrini, M.; Trentani, P.; Barbieri, E.

In: Journal of Bone and Joint Surgery - Series B, Vol. 85, No. 1, 01.2003, p. 107-114.

Research output: Contribution to journalArticle

@article{211042669fd54f27817fbc0045a26da3,
title = "Local and systemic control in Ewing's sarcoma of the femur treated with chemotherapy, and locally by radiotherapy and/or surgery",
abstract = "The role of radiotherapy and/or surgery in the local treatment of Ewing's sarcoma has still to be determined. The outcome of Ewing's sarcoma may differ according to its location and a selection bias towards surgery limits the ability to compare methods of local treatment. We have carried out a retrospective review of 91 consecutive patients treated for non-metastatic Ewing's sarcoma of the femur. They received chemotherapy according to four different protocols. The primary lesion was treated by surgery alone (54 patients), surgery and radiotherapy (13) and radiotherapy alone (23). One was treated by chemotherapy alone. At a median follow-up of ten years, 48 patients (53{\%}) remain free from disease, 39 (43{\%}) have relapsed, two (2{\%}) have died from chemotherapeutic toxicity and two (2{\%}) have developed a radio-induced second tumour. The probability of survival without local recurrence was significantly (p = 0.01) higher in patients who were treated by surgery with or without radiotherapy (88{\%}) than for patients who received radiotherapy alone (59{\%}). The five- and ten-year overall survival rates were 64{\%} and 57{\%}, respectively. Patients who were treated by surgery, with or without radiotherapy, had a five- and ten-year overall survival of 64{\%}. Patients who received only radiotherapy had a five- and ten-year survival of 57{\%} and 44{\%}, respectively. Our results indicate that in patients with Ewing's sarcoma of the femur, better local control is achieved by surgical treatment (with or without radiotherapy) compared with the use of radiotherapy alone. Further studies are needed to verify the impact of this strategy on overall survival.",
author = "G. Bacci and S. Ferrari and A. Longhi and M. Versari and C. Forni and D. Donati and M. Manfrini and P. Trentani and E. Barbieri",
year = "2003",
month = "1",
doi = "10.1302/0301-620X.85B1.12781",
language = "English",
volume = "85",
pages = "107--114",
journal = "Journal of Bone and Joint Surgery - Series B",
issn = "0301-620X",
publisher = "British Editorial Society of Bone and Joint Surgery",
number = "1",

}

TY - JOUR

T1 - Local and systemic control in Ewing's sarcoma of the femur treated with chemotherapy, and locally by radiotherapy and/or surgery

AU - Bacci, G.

AU - Ferrari, S.

AU - Longhi, A.

AU - Versari, M.

AU - Forni, C.

AU - Donati, D.

AU - Manfrini, M.

AU - Trentani, P.

AU - Barbieri, E.

PY - 2003/1

Y1 - 2003/1

N2 - The role of radiotherapy and/or surgery in the local treatment of Ewing's sarcoma has still to be determined. The outcome of Ewing's sarcoma may differ according to its location and a selection bias towards surgery limits the ability to compare methods of local treatment. We have carried out a retrospective review of 91 consecutive patients treated for non-metastatic Ewing's sarcoma of the femur. They received chemotherapy according to four different protocols. The primary lesion was treated by surgery alone (54 patients), surgery and radiotherapy (13) and radiotherapy alone (23). One was treated by chemotherapy alone. At a median follow-up of ten years, 48 patients (53%) remain free from disease, 39 (43%) have relapsed, two (2%) have died from chemotherapeutic toxicity and two (2%) have developed a radio-induced second tumour. The probability of survival without local recurrence was significantly (p = 0.01) higher in patients who were treated by surgery with or without radiotherapy (88%) than for patients who received radiotherapy alone (59%). The five- and ten-year overall survival rates were 64% and 57%, respectively. Patients who were treated by surgery, with or without radiotherapy, had a five- and ten-year overall survival of 64%. Patients who received only radiotherapy had a five- and ten-year survival of 57% and 44%, respectively. Our results indicate that in patients with Ewing's sarcoma of the femur, better local control is achieved by surgical treatment (with or without radiotherapy) compared with the use of radiotherapy alone. Further studies are needed to verify the impact of this strategy on overall survival.

AB - The role of radiotherapy and/or surgery in the local treatment of Ewing's sarcoma has still to be determined. The outcome of Ewing's sarcoma may differ according to its location and a selection bias towards surgery limits the ability to compare methods of local treatment. We have carried out a retrospective review of 91 consecutive patients treated for non-metastatic Ewing's sarcoma of the femur. They received chemotherapy according to four different protocols. The primary lesion was treated by surgery alone (54 patients), surgery and radiotherapy (13) and radiotherapy alone (23). One was treated by chemotherapy alone. At a median follow-up of ten years, 48 patients (53%) remain free from disease, 39 (43%) have relapsed, two (2%) have died from chemotherapeutic toxicity and two (2%) have developed a radio-induced second tumour. The probability of survival without local recurrence was significantly (p = 0.01) higher in patients who were treated by surgery with or without radiotherapy (88%) than for patients who received radiotherapy alone (59%). The five- and ten-year overall survival rates were 64% and 57%, respectively. Patients who were treated by surgery, with or without radiotherapy, had a five- and ten-year overall survival of 64%. Patients who received only radiotherapy had a five- and ten-year survival of 57% and 44%, respectively. Our results indicate that in patients with Ewing's sarcoma of the femur, better local control is achieved by surgical treatment (with or without radiotherapy) compared with the use of radiotherapy alone. Further studies are needed to verify the impact of this strategy on overall survival.

UR - http://www.scopus.com/inward/record.url?scp=0037272819&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037272819&partnerID=8YFLogxK

U2 - 10.1302/0301-620X.85B1.12781

DO - 10.1302/0301-620X.85B1.12781

M3 - Article

VL - 85

SP - 107

EP - 114

JO - Journal of Bone and Joint Surgery - Series B

JF - Journal of Bone and Joint Surgery - Series B

SN - 0301-620X

IS - 1

ER -